Betta Pharmaceuticals Co.,Ltd.(300558),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

300558 Betta Pharmaceuticals Co.,Ltd.

Closed 12-12 15:00:00

47.70

-0.42

-0.87%

High48.29	Low47.15	Vol5.56M
Open48.00	D1 Closing48.12	Amplitude2.37%
Mkt Cap20.08B	Tradable Cap19.99B	Total Shares421.00M
T/O265.00M	T/O Rate1.33%	Tradable Shares419.00M
P/B3.46	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"300558","market":"SZ","secType":"STK","nameCN":"Betta Pharmaceuticals Co.,Ltd.","latestPrice":47.7,"timestamp":1765523016000,"preClose":48.12,"halted":0,"volume":5558739,"delay":0,"changeRate":-0.0087,"floatShares":419000000,"shares":421000000,"eps":0.7209,"marketStatus":"Closed","change":-0.42,"latestTime":"12-12 15:00:00","open":48,"high":48.29,"low":47.15,"amount":265000000,"amplitude":0.0237,"askPrice":47.75,"askSize":6,"bidPrice":47.7,"bidSize":92,"shortable":0,"etf":0,"ttmEps":0.7209,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":48.12,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":52.93,"lowLimit":43.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":420733843,"isCdr":false,"pbRate":3.46,"roa":"--","peRate":66.167291,"roe":"5.5%","epsLYR":0.96,"committee":0.168459,"marketValue":20069000000,"turnoverRate":0.0133,"status":1,"floatMarketCap":20005000000},"requestUrl":"/m/hq/s/300558/wiki","defaultTab":"wiki","newsList":[{"id":"2589386459","title":"Betta Pharmaceuticals's Four Drugs Placed on China's Insurance Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=2589386459","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589386459?lang=en_us&edition=fundamental","pubTime":"2025-12-08 12:47","pubTimestamp":1765169266,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals'  four cancer drugs were included in China's National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug List, according to a Shenzhen bourse filing on Monday.The drugs are icotinib hydrochloride tablets, ensartinib hydrochloride capsules, befotertinib mesylate capsules and vorolanib tablets.The new list will be effective on Jan. 1, 2026, the pharmaceutical company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0060","300558"],"gpt_icon":0},{"id":"1184060233","title":"Betta Pharmaceuticals (300558.SZ): Ensartinib Hydrochloride Capsules' Marketing Authorization Application Accepted by EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1184060233","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184060233?lang=en_us&edition=fundamental","pubTime":"2025-11-28 15:56","pubTimestamp":1764316578,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co., Ltd. (300558.SZ) announced that its subsidiary Xcovery received notification from the European Medicines Agency (EMA) regarding the acceptance of its marketing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300558","91287","BK0239","BK0060"],"gpt_icon":0},{"id":"1123336276","title":"Betta Pharmaceuticals (300558.SZ): Drug Registration Application for Ensartinib Hydrochloride Capsules as Postoperative Adjuvant Therapy Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1123336276","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123336276?lang=en_us&edition=fundamental","pubTime":"2025-11-26 12:12","pubTimestamp":1764130331,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co., Ltd. (300558.SZ) announced that it has received the \"Acceptance Notice\" (Acceptance No.: CXHS2500142, CXHS2500143) issued by the National Medical Products Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300558","91287","BK0060","BK0239"],"gpt_icon":0},{"id":"1198775789","title":"Betta Pharmaceuticals' Third Attempt at Hong Kong IPO: Cash Crunch, Product Gap, and R&D Cuts – Can the \"Four-Pronged Strategy\" Save the Day?","url":"https://stock-news.laohu8.com/highlight/detail?id=1198775789","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198775789?lang=en_us&edition=fundamental","pubTime":"2025-11-07 17:20","pubTimestamp":1762507257,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals recently announced its plan to issue H-shares and list on the Hong Kong Stock Exchange's main board. This marks the company's third attempt to go public in Hong Kong within four...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91287","HEXmain","BK0060","BK0239","300558"],"gpt_icon":0},{"id":"1137685215","title":"Betta Pharmaceuticals: BPI-572270 is a molecular glue inhibitor, currently advancing IND submission preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=1137685215","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137685215?lang=en_us&edition=fundamental","pubTime":"2025-11-06 12:50","pubTimestamp":1762404642,"startTime":"0","endTime":"0","summary":"According to investor inquiries on the interactive platform, Betta Pharmaceuticals Co., Ltd. (300558.SZ) stated on November 6 that BPI-572270, a molecular glue inhibitor, is currently progressing...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","300558","BK0239","BPI","91287"],"gpt_icon":0},{"id":"2580252580","title":"Betta Pharmaceuticals Gets Distribution Rights for Hemophilia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2580252580","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580252580?lang=en_us&edition=fundamental","pubTime":"2025-11-03 12:00","pubTimestamp":1762142456,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals (SHE:300558) obtained exclusive general distribution rights for the recombinant human coagulation factor VIII-Fc fusion protein for injection (FRSW117) in the Greater China regio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300558","BK0060","BK0239"],"gpt_icon":0},{"id":"1107452024","title":"A-Share Innovative Drug Concept Stocks Decline, Betta Pharmaceuticals Falls Over 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107452024","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107452024?lang=en_us&edition=fundamental","pubTime":"2025-10-14 14:31","pubTimestamp":1760423500,"startTime":"0","endTime":"0","summary":"On October 14th, A-share innovative drug concept stocks experienced volatile declines. Betta Pharmaceuticals Co.,Ltd. dropped more than 10%, while Jincheng Medicine, Kangchen Pharmaceutical, Baili Tianheng, Olin Biology, and Changchun High & New Technology also fell by over 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK1161","BK0239","06978","159992","399300","91287","159982","BK1574","300558"],"gpt_icon":0},{"id":"2571362388","title":"Betta Pharmaceuticals  Says Co Has Submitted Listing Apllication to Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2571362388","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571362388?lang=en_us&edition=fundamental","pubTime":"2025-09-30 08:13","pubTimestamp":1759191211,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nL3N3VH00Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["300558","BK0239","BK0060"],"gpt_icon":0},{"id":"2571334362","title":"BRIEF-Betta Pharmaceuticals Submits Listing Application To Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2571334362","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571334362?lang=en_us&edition=fundamental","pubTime":"2025-09-30 08:13","pubTimestamp":1759191211,"startTime":"0","endTime":"0","summary":"BRIEF-Betta Pharmaceuticals Submits Listing Application To Hong Kong Stock ExchangeSept 30  - Betta Pharmaceuticals Co Ltd 300558.SZ:SAYS CO HAS SUBMITTED LISTING APLLICATION TO HONG KONG STOCK EXCHANGESource textFurther company coverage: 300558.SZ  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nL3N3VH00Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300558","BK0060","BK0239"],"gpt_icon":0},{"id":"1181442287","title":"IPO News | Betta Pharmaceuticals Co.,Ltd. (300558.SZ) Files Application with Hong Kong Stock Exchange, Successfully Transforms into \"Platform-Type Pharmaceutical Enterprise\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1181442287","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181442287?lang=en_us&edition=fundamental","pubTime":"2025-09-30 06:52","pubTimestamp":1759186352,"startTime":"0","endTime":"0","summary":"According to disclosures from the Hong Kong Stock Exchange on September 29, Betta Pharmaceuticals Co.,Ltd. (300558.SZ) has submitted its listing application to the main board of the Hong Kong Stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","BK0239","HEXmain","01477","BK0060","300558"],"gpt_icon":0},{"id":"1194196477","title":"Betta Pharmaceuticals, \"China's First Innovative Drug Stock,\" Makes Third Attempt at Hong Kong IPO Amid Profit Struggles and 180 Million Yuan Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=1194196477","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194196477?lang=en_us&edition=fundamental","pubTime":"2025-09-18 20:21","pubTimestamp":1758198089,"startTime":"0","endTime":"0","summary":"Veteran innovative drug company Betta Pharmaceuticals Co.,Ltd. stands at a critical juncture as it announced its third Hong Kong stock offering plan on September 11. Founded in 2003, Betta...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07226","159982","BK4614","06978","YANG","300558","BK0060","399300","159992","BK1161","HSCEI","HSTECH","BK0239","BK1574"],"gpt_icon":1},{"id":"1196527783","title":"Betta Pharmaceuticals Seeks Third Hong Kong IPO with 500 Million Yuan in Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=1196527783","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196527783?lang=en_us&edition=fundamental","pubTime":"2025-09-17 07:21","pubTimestamp":1758064900,"startTime":"0","endTime":"0","summary":"A-share innovative drug veteran Betta Pharmaceuticals Co.,Ltd. (300558.SZ) is making its third attempt at a Hong Kong IPO. Recently, Betta Pharmaceuticals disclosed an announcement stating its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK4614","BK0239","YANG","HSTECH","07226","HSCEI","300558"],"gpt_icon":1},{"id":"2566793002","title":"Betta Pharmaceuticals Gets Board Approval for Hong Kong Listing Plan; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566793002","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566793002?lang=en_us&edition=fundamental","pubTime":"2025-09-11 11:35","pubTimestamp":1757561713,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals  obtained board approval for its plan to issue H shares and list on the Hong Kong bourse, according to a Thursday filing on the Shenzhen bourse.The plan is subject to authorization from China's securities regulator, the Hong Kong bourse, and other relevant government authorities and regulators.Shares of the pharmaceutical company fell 4% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","300558","BK0060"],"gpt_icon":0},{"id":"2566606425","title":"Betta Pharmaceuticals  Says Co Plans to Seek Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2566606425","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566606425?lang=en_us&edition=fundamental","pubTime":"2025-09-10 20:26","pubTimestamp":1757507206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nL3N3UX0WV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["300558","BK0060","BK0239"],"gpt_icon":0},{"id":"2566606404","title":"BRIEF-Betta Pharmaceuticals Plans To Seek Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2566606404","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566606404?lang=en_us&edition=fundamental","pubTime":"2025-09-10 20:26","pubTimestamp":1757507206,"startTime":"0","endTime":"0","summary":"BRIEF-Betta Pharmaceuticals Plans To Seek Hong Kong ListingSept 10 (Reuters) - Betta Pharmaceuticals Co Ltd 300558.SZ:SAYS CO PLANS TO SEEK HONG KONG LISTINGSource textFurther company coverage: 300558.SZ (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nL3N3UX0WV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0239","300558"],"gpt_icon":0},{"id":"1197441883","title":"Betta Pharmaceuticals Co.,Ltd., the \"First Innovative Drug Stock,\" Sees Profit Growth Hit the Brakes","url":"https://stock-news.laohu8.com/highlight/detail?id=1197441883","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197441883?lang=en_us&edition=fundamental","pubTime":"2025-08-21 07:01","pubTimestamp":1755730868,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co.,Ltd. (300558) delivered a half-year report on August 20 showing revenue growth without profit improvement. The company's net profit for the first half declined to 140...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK0060","BK0239","BK1161","300558","06978","159992"],"gpt_icon":0},{"id":"2560066176","title":"Betta Pharmaceuticals' Attributable Profit Slides 38% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2560066176","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560066176?lang=en_us&edition=fundamental","pubTime":"2025-08-20 17:27","pubTimestamp":1755682033,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals  attributable profit fell 38% to 139.9 million yuan in the first half from 223.9 million yuan in the year-ago period, according to a Wednesday filing with the Shenzhen bourse.Earnings per share at the pharmaceutical company declined 39% to 0.33 yuan from 0.54 yuan in the prior-year period.Operating income increased 15% to 1.73 billion yuan from 1.50 billion yuan in the year-ago period.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300558","BK0060","BK0239"],"gpt_icon":0},{"id":"1110523126","title":"Betta Pharmaceuticals Co.,Ltd. (300558.SZ) Reports First-Half Results with Net Profit of 140 Million Yuan, Down 37.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110523126","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110523126?lang=en_us&edition=fundamental","pubTime":"2025-08-19 18:58","pubTimestamp":1755601095,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co.,Ltd. (300558.SZ) released its 2025 interim report, showing operating revenue of 17.31 billion yuan, representing a year-on-year increase of 15.37%. Net profit attributable...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300558","BK0060","BK0239"],"gpt_icon":0},{"id":"2557552057","title":"C4 Therapeutics Inc. Releases Presentation on Targeted Protein Degradation Advancements and Future Development Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2557552057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557552057?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:07","pubTimestamp":1754564860,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Inc. has released a corporate presentation detailing advancements in their portfolio of degrader medicines aimed at transforming patient lives through targeted protein degradation. The presentation highlights the company's work in designing orally bioavailable degraders, with a focus on multiple myeloma and collaborations with leading global pharmaceutical companies. It also discusses the decision not to advance CFT1946 beyond Phase 1 trials and plans to seek partnerships for the BRAF program. Additionally, there is a mention of a license and collaboration agreement with Betta Pharmaceuticals for activities in Greater China. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or le","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL8JTJpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","300558","CCCC","BK4139","BK0239"],"gpt_icon":0},{"id":"1194645411","title":"Beta Pharma (300558.SZ) Reports Partner He Yuan Biotech's Novel Drug Ofumin Gains Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1194645411","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194645411?lang=en_us&edition=fundamental","pubTime":"2025-07-18 19:42","pubTimestamp":1752838944,"startTime":"0","endTime":"0","summary":"Beta Pharma Co., Ltd. (300558.SZ) announced its equity-method investee Wuhan He Yuan Biotechnology Co., Ltd. has secured regulatory approval for recombinant human serum albumin injection...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","300558","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-07","address":"浙江省杭州市临平区经济技术开发区兴中路355号","stockEarnings":[{"period":"1week","weight":0.0006},{"period":"1month","weight":-0.1152},{"period":"3month","weight":-0.3256},{"period":"6month","weight":-0.2444},{"period":"1year","weight":-0.1263},{"period":"ytd","weight":-0.1127}],"companyName":"贝达药业股份有限公司","boardCode":"AI0027","perCapita":"12065股","boardName":"医药制造业","registeredCapital":"42073万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　贝达药业股份有限公司的主营业务是创新药物的生产与销售。公司的主要产品是凯美纳、贝美纳、贝安汀、赛美纳、伏美纳、康美纳、安瑞泽、奥福民。","serverTime":1765706725810,"listedPrice":17.57,"stockholders":"34761人(较上一季度增加17.69%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Betta Pharmaceuticals Co.,Ltd.(300558),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Betta Pharmaceuticals Co.,Ltd.(300558) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Betta Pharmaceuticals Co.,Ltd.,300558,Betta Pharmaceuticals Co.,Ltd.股票,Betta Pharmaceuticals Co.,Ltd.股票老虎,Betta Pharmaceuticals Co.,Ltd.股票老虎国际,Betta Pharmaceuticals Co.,Ltd.行情,Betta Pharmaceuticals Co.,Ltd.股票行情,Betta Pharmaceuticals Co.,Ltd.股价,Betta Pharmaceuticals Co.,Ltd.股市,Betta Pharmaceuticals Co.,Ltd.股票价格,Betta Pharmaceuticals Co.,Ltd.股票交易,Betta Pharmaceuticals Co.,Ltd.股票购买,Betta Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Betta Pharmaceuticals Co.,Ltd.(300558),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Betta Pharmaceuticals Co.,Ltd.(300558) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction